Online inquiry

IVTScrip™ mRNA-Human ADAD2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8886MR)

This product GTTS-WK8886MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADAD2 protein. This product can be used in Meiotic prophase fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001145400.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 161931
UniProt ID Q8NCV1
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADAD2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8886MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK12818MR IVTScrip™ mRNA-Human ADCK5, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ADCK5
GTTS-WK27430MR IVTScrip™ mRNA-Human ARIH2, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARIH2
GTTS-WK25200MR IVTScrip™ mRNA-Human ATP5F1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ATP5F1
GTTS-WK19622MR IVTScrip™ mRNA-Human Alkaline phosphatase, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA Alkaline phosphatase
GTTS-WK21381MR IVTScrip™ mRNA-Human AKT2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AKT2
GTTS-WK18720MR IVTScrip™ mRNA-Human ALK4, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ALK4
GTTS-WK10521MR IVTScrip™ mRNA-Human AASDH, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA AASDH
GTTS-WK7804MR IVTScrip™ mRNA-Human 3A7, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA 3A7
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW